Epanolol

{{chembox

| ImageFile=Epanolol.svg

| IUPACName=(RS)-N-[2-([3-(2-cyanophenoxy)-2-hydroxypropyl]amino)ethyl]-2-(4-hydroxyphenyl)acetamide

| OtherNames=

|Section1={{Chembox Identifiers

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 9KGC55KP6A

| CASNo_Ref = {{cascite|correct|??}}

| CASNo=86880-51-5

| PubChem=72014

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D06646

| SMILES=C1=CC=C(C(=C1)C#N)OCC(CNCCNC(=O)CC2=CC=C(C=C2)O)O

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 65013

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C20H23N3O4/c21-12-16-3-1-2-4-19(16)27-14-18(25)13-22-9-10-23-20(26)11-15-5-7-17(24)8-6-15/h1-8,18,22,24-25H,9-11,13-14H2,(H,23,26)

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = YARKMNAWFIMDKV-UHFFFAOYSA-N

}}

|Section2={{Chembox Properties

| Formula=C₂₀H₂₃N₃O₄

| MolarMass=369.41432

| Appearance=

| Density=

| MeltingPt=

| BoilingPt=

| Solubility=

}}

|Section6={{Chembox Pharmacology

| ATCCode_prefix = C07

| ATCCode_suffix = AB10

}}

|Section7={{Chembox Hazards

| MainHazards=

| FlashPt=

| AutoignitionPt =

}}

}}

Epanolol is a beta blocker.{{Cite journal | last1 = Hosie | first1 = J. | last2 = Scott | first2 = A. K. | last3 = Petrie | first3 = J. C. | last4 = Cockshott | first4 = I. D. | title = Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris | journal = British Journal of Clinical Pharmacology | volume = 29 | issue = 3 | pages = 333–337 | year = 1990 | pmid = 1968755 | pmc = 1380134 | doi=10.1111/j.1365-2125.1990.tb03644.x }} developed by Imperial Chemical Industries.{{cite journal |doi=10.1021/jm00353a004 |title=.beta.-Adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols |date=1982 |last1=Large |first1=M. S. |last2=Smith |first2=L. H. |journal=Journal of Medicinal Chemistry |volume=25 |issue=11 |pages=1286–1292 |pmid=6128420 }}